Entera Bio Ltd. ( ENTX) - Key Metrics
ENTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.14 | -$0.07 | -$0.07 |
| 2026Q1 | $0 | -$0.07 | -$0.06 | -$0.06 |
| 2025Q4 | $0 | -$0.07 | -$0.04 | -$0.04 |
| 2025Q3 | $0 | -$0.07 | -$0.06 | -$0.06 |
| 2025Q2 | $0 | -$0.06 | -$0.03 | -$0.04 |
ENTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.16 |
| 2026Q1 | 0% | -3.78 |
| 2025Q4 | 0% | -7.43 |
| 2025Q3 | 0% | -7.06 |
| 2025Q2 | 0% | -8.38 |
ENTX
Price: $2.77
52 week price:
Earnings Per Share: -0.35 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 1891
Market Capitalization: 124.7 million